Longboard Pharmaceuticals...

NASDAQ: LBPH · Real-Time Price · USD
59.98
null (null%)
At close: Nov 29, 2024, 7:00 PM
undefined%
Bid n/a
Market Cap 2.34B
Revenue (ttm) 8K
Net Income (ttm) -76.34M
EPS (ttm) -2.25
PE Ratio (ttm) -26.657777777777778
Forward PE -18.57
Analyst Hold
Ask n/a
Volume 0
Avg. Volume (20D) 0
Open undefined
Previous Close undefined
Day's Range 59.98 - 59.98
52-Week Range 59.98 - 59.98
Beta 1.09

About LBPH

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LBPH
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LBPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
10 months ago
+51.65%
Longboard Pharmaceuticals shares are trading highe... Unlock content with Pro Subscription
11 months ago
+13.95%
Longboard Pharmaceuticals shares are trading higher after the company announced it received rare pediatric disease and orphan drug designations from the FDA for bexicaserin (LP352) in Dravet syndrome.